China NMPA Drug Inspection - Sichuan Gukang Pharmaceutical Co., Ltd. - Lotus seed heart
China NMPA drug inspection for Sichuan Gukang Pharmaceutical Co., Ltd. published October 22, 2020. Drug: Lotus seed heart. On October 22, 2020, the Chongqing Municipal Drug Administration released an announcement regarding 45 batches of tradit
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Sichuan Gukang Pharmaceutical Co., Ltd. published October 22, 2020. Drug: Lotus seed heart. On October 22, 2020, the Chongqing Municipal Drug Administration released an announcement regarding 45 batches of tradit
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox